Renal Failure, CKD, Dialysis & AV Fistulas — Clinical Documentation Guide (2026)

This Clinical Documentation Guide (CDG) is the master renal reference for CCO-credentialed coders, CDI specialists, and auditors. It provides comprehensive guidance on coding Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD) stages 1–5/ESRD, dialysis dependence, AV fistula complications, kidney transplant, and all related conditions. Content reflects FY2026 ICD-10-CM guidelines (effective October 1, 2025 – September 30, 2026), CY2026 CPT, HCPCS, and CMS-HCC v28 risk adjustment weights.

🔍 1. Definition

Acute Kidney Injury (AKI) is a sudden, reversible (or potentially reversible) deterioration in renal function occurring over hours to days, resulting in the retention of nitrogenous waste products and dysregulation of fluid, electrolyte, and acid-base homeostasis. AKI is defined by the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 Clinical Practice Guidelines as any of the following: an increase in serum creatinine ≥0.3 mg/dL within 48 hours, an increase in serum creatinine to ≥1.5× baseline within 7 days, or urine output <0.5 mL/kg/h for ≥6 hours.

Chronic Kidney Disease (CKD) is a progressive, irreversible condition characterized by structural or functional kidney abnormalities present for >3 months, as defined by KDIGO CKD guidelines. CKD is staged according to estimated glomerular filtration rate (eGFR) using the CKD-EPI equation and the degree of albuminuria. Stages range from G1 (eGFR ≥90 mL/min/1.73m²) with kidney damage markers, through G5 (eGFR <15 mL/min/1.73m²), and ultimately End-Stage Renal Disease (ESRD) requiring renal replacement therapy (RRT).

End-Stage Renal Disease (ESRD) is the final, permanent stage of CKD in which kidney function has deteriorated to the point where the kidneys can no longer maintain life without renal replacement therapy — hemodialysis (HD), peritoneal dialysis (PD), or kidney transplantation. In ICD-10-CM, ESRD is uniquely represented by N18.6 and must always be paired with Z99.2 (dependence on renal dialysis) when the patient is actively dialyzed, per ICD-10-CM Official Guidelines for Coding and Reporting, Section I.C.14.

Arteriovenous (AV) Fistula is a surgically created anastomosis between an artery and vein, typically in the forearm or upper arm, used as the preferred vascular access for hemodialysis. AV fistulas provide high flow rates, long-term patency, and lower infection risk compared to grafts or catheters. Complications include stenosis, thrombosis, steal syndrome, aneurysm, and infection, as described by the National Kidney Foundation (NKF).

Epidemiology & Public Health Impact

According to U.S. Renal Data System (USRDS) Annual Data Report 2023, approximately 37 million Americans (14.9% of U.S. adults) have CKD, the vast majority undiagnosed. Over 800,000 people in the U.S. live with ESRD, and roughly 135,000 patients initiate dialysis annually. CKD is the 9th leading cause of death in the United States and is a major driver of Medicare expenditure, accounting for over $125 billion in Medicare costs annually. AKI affects approximately 10–15% of all hospitalized patients and >50% of ICU patients, per StatPearls: Acute Kidney Injury (NCBI).

🗂️ 2. Alternative Terminology

🩺 3. Signs & Symptoms

Acute Kidney Injury Signs & Symptoms

• Oliguria — urine output <400 mL/24h (most sensitive indicator of significant AKI)
• Anuria — urine output <100 mL/24h (suggests severe obstruction, cortical necrosis, or bilateral vascular occlusion)
• Rising creatinine/BUN — elevation from baseline (by KDIGO staging criteria)
• Fluid overload — edema, hypertension, pulmonary congestion, weight gain
• Electrolyte disturbances — hyperkalemia (most dangerous: cardiac arrhythmias), hyperphosphatemia, hyponatremia, metabolic acidosis
• Uremic symptoms — nausea, vomiting, altered mental status, asterixis (uremic flap), pericardial friction rub (uremic pericarditis)
• Hematuria — may suggest intrinsic causes (GN, ATN with pigmented casts)
• Proteinuria/casts — muddy brown granular casts (ATN), RBC casts (GN), WBC casts (pyelonephritis/AIN)

Chronic Kidney Disease Signs & Symptoms

• Early CKD (Stages 1–3) — often asymptomatic; detected via routine urinalysis, eGFR calculation, or microalbuminuria screening
• Moderate CKD (Stage 3–4) — fatigue, nocturia, mild edema, hypertension (frequently present), mild anemia (D63.1), decreased appetite
• Advanced CKD/ESRD (Stage 5) — severe fatigue, dyspnea, peripheral edema, uremic pruritus, metallic taste, cognitive impairment, restless leg syndrome, bone disease (renal osteodystrophy), secondary hyperparathyroidism
• Cardiovascular — accelerated atherosclerosis, LV hypertrophy, pericarditis, arrhythmias (hyperkalemia-driven)
• Hematologic — normochromic, normocytic anemia due to EPO deficiency; platelet dysfunction; increased bleeding tendency
• Dermatologic — uremic frost (severe, late finding), sallow complexion, calciphylaxis (vascular calcification with skin necrosis)
• Musculoskeletal — renal osteodystrophy (osteitis fibrosa cystica, osteomalacia), secondary hyperparathyroidism, gout/pseudogout (hyperuricemia)

AV Fistula Complication Signs & Symptoms

• Stenosis — reduced thrill/bruit, prolonged bleeding post-needling, high venous pressure during HD, inadequate dialysis (Kt/V)
• Thrombosis — absent thrill/bruit, swelling proximal to access, failure to dialyze adequately
• Steal syndrome — hand pain, pallor, paresthesias, weakness distal to access; worsens during HD
• Infection — erythema, warmth, tenderness, purulent discharge at access site; fever, bacteremia/septicemia
• Aneurysm/pseudoaneurysm — pulsatile bulging at access site; rupture risk

🧭 4. Differential Diagnosis

📋 5. Clinical Indicators for Coders/CDI

🦴 6. Anatomy & Pathophysiology

Normal Kidney Anatomy

The kidneys are paired retroperitoneal organs, each weighing approximately 120–170g in adults. Each kidney contains approximately 1 million nephrons — the functional units responsible for filtration, reabsorption, and secretion. The nephron consists of the renal corpuscle (glomerulus + Bowman's capsule), proximal convoluted tubule, loop of Henle, distal convoluted tubule, and collecting duct. The glomerulus filters approximately 180 liters of plasma per day, producing a filtrate that is subsequently concentrated to approximately 1–2 liters of urine. The kidneys regulate fluid balance, electrolyte homeostasis (sodium, potassium, phosphorus, calcium, bicarbonate), acid-base balance, blood pressure (via the renin-angiotensin-aldosterone system), erythropoiesis (via EPO production), and vitamin D activation (25-OH-D3 → 1,25-(OH)2-D3 in the proximal tubule), as reviewed in StatPearls: Kidney Anatomy (NCBI).

Pathophysiology of AKI

AKI is classified by etiology into three categories, per KDIGO AKI guidelines:

• Prerenal AKI: Reduced renal perfusion (hypovolemia, decreased cardiac output, renal vasoconstriction) without structural kidney damage. Reversible with restoration of perfusion. BUN:Cr ratio typically >20:1; FENa <1%.
• Intrinsic (Renal) AKI: Direct damage to kidney parenchyma. The most common form is acute tubular necrosis (ATN), caused by ischemic or nephrotoxic insults to the proximal tubule and thick ascending limb of the loop of Henle. Other forms include acute interstitial nephritis (AIN — drug or immune-mediated), acute glomerulonephritis (GN), and vascular causes (thrombotic microangiopathy, renal artery thrombosis).
• Postrenal AKI: Obstruction of urinary flow at any level (ureteral, bladder outlet, urethral). Causes include BPH, ureteral stones, pelvic malignancy, bilateral ureteral obstruction. Early relief of obstruction restores function; prolonged obstruction leads to permanent damage.

Pathophysiology of CKD Progression

CKD progression involves a common final pathway of glomerular hypertension, proteinuria-driven tubular injury, and interstitial fibrosis/tubular atrophy (IFTA) regardless of the initial insult. Key mechanisms include:

• Glomerulosclerosis: Progressive loss of functioning nephrons leads to hyperfiltration in remaining nephrons, promoting glomerular hypertension and scarring
• TGF-β pathway activation: Drives fibrogenesis, myofibroblast activation, and interstitial fibrosis — the histologic hallmark of CKD progression
• Renin-angiotensin-aldosterone system (RAAS) activation: Angiotensin II drives efferent vasoconstriction, intraglomerular hypertension, inflammation, and fibrosis; hence ACEi/ARBs are first-line renoprotective therapy
• Proteinuria-mediated tubular injury: Filtered proteins activate tubular cells to produce inflammatory mediators, exacerbating interstitial fibrosis
• Uremic toxin accumulation: As eGFR falls, urea, creatinine, phosphorus, potassium, organic anions, and protein-bound uremic toxins accumulate, driving systemic complications

Pathophysiology of ESRD & Dialysis

When eGFR falls below 10–15 mL/min/1.73m², uremia becomes life-threatening without renal replacement therapy. Hemodialysis clears uremic solutes via diffusion across a semi-permeable membrane using a dialysate solution. Peritoneal dialysis utilizes the peritoneal membrane as the filter, with dialysate instilled into the peritoneal cavity. Both modalities remove uremic toxins, correct fluid overload, and partially restore electrolyte and acid-base balance, but neither restores endocrine functions (EPO production, vitamin D activation) — hence the need for erythropoiesis-stimulating agents (ESAs) and active vitamin D supplementation, per UpToDate: Overview of CKD Management.

💊 7. Medication Impact / Treatment

Key Medications and Coding Implications

Preview ends here. The full guide continues with FY2026 ICD-10-CM code sets, CPT surgical coding, MS-DRG mapping, reimbursement guidance, CDI query templates, and an audit checklist — all available to CCO Members.

← Back to All Clinical Documentation Guides